| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.PEPTIDES.2004.08.034 |
| P698 | PubMed publication ID | 15911076 |
| P2093 | author name string | Angelika M Vollmar | |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atrial natriuretic peptide | Q78185357 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1086-1094 | |
| P577 | publication date | 2005-04-14 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | The role of atrial natriuretic peptide in the immune system | |
| P478 | volume | 26 |
| Q35792035 | ANP/NPRA signaling preferentially mediates Th2 responses in favor of pathological processes during the course of acute allergic asthma |
| Q38816005 | Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells. |
| Q37249880 | Atrial natriuretic peptide down-regulates neutrophil recruitment on inflamed endothelium by reducing cell deformability and resistance to detachment force |
| Q37138941 | Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion. |
| Q39502711 | Atrial natriuretic peptide induces peroxisome proliferator activated receptor γ during cardiac ischemia-reperfusion in swine heart. |
| Q57420152 | Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue |
| Q95660687 | Cardiac natriuretic peptides |
| Q39604148 | Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution |
| Q37058407 | Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy |
| Q64901040 | Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. |
| Q91925291 | Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients |
| Q37336602 | Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation |
| Q92879308 | Emerging concepts of receptor endocytosis and concurrent intracellular signaling: Mechanisms of guanylyl cyclase/natriuretic peptide receptor-A activation and trafficking |
| Q37345377 | Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A. |
| Q92641654 | Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction |
| Q52579764 | Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. |
| Q36876093 | Genetic mechanisms of atrial fibrillation: impact on response to treatment |
| Q35936915 | Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation |
| Q40265394 | Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory as |
| Q38695069 | Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure |
| Q47849831 | Natriuretic Peptides: The Case of Prostate Cancer |
| Q36425960 | Natriuretic peptides as therapeutic targets |
| Q54945407 | Natriuretic peptides system in the pulmonary tissue of rats with heart failure: potential involvement in lung edema and inflammation. |
| Q35250982 | Pathophysiology of the Behçet's Disease |
| Q36067274 | Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance |
| Q44825812 | Psychosocial correlates of atrial natriuretic peptide: a marker of vascular health |
| Q36140769 | Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes |
| Q37124563 | Regulation and function of cyclic GMP-mediated pathways in glial cells |
| Q35050007 | Regulation of cardiac angiotensin-converting enzyme and angiotensin AT1 receptor gene expression in Npr1 gene-disrupted mice |
| Q38369393 | Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: benefits of atrial natriuretic peptide, losartan, and tempol |
| Q40381788 | Role of anterior hypothalamic natriuretic peptide in lipopolysaccharide-induced fever in rats |
| Q81091749 | Serum levels of natriuretic peptides in patients with Behcet's disease |
| Q38272996 | Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system |
| Q58027445 | Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis |
| Q56703479 | The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells |
| Q39078020 | The association of fever with transfusion-associated circulatory overload. |
| Q48138226 | The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes |
| Q37286819 | The role of atrial natriuretic peptide to attenuate inflammation in a mouse skin wound and individually perfused rat mesenteric microvessels |
Search more.